M.D. Anderson Cancer Center
Extra copies of A. fumigatus squalene epoxidase gene confer resistance to terbinafine
Published in Genetics and Environmental Law Weekly, September 18th, 2004
According to a study from the United States, "With the increasing use of antifungals such as amphotericin B, itraconazole, voriconazole, caspofungin, and terbinafine (TRB) in patients at high risk for invasive aspergillosis, resistance of Aspergillus fumigatus to these agents will ultimately emerge.
"Due to the limited availability of molecular genetics for A. fumigatus, few studies have addressed its mechanisms of resistance to antifungals."
"We transformed A. fumigatus protoplasts with a pyrG-based A....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
More Articles from Genetics and Environmental Law Weekly
- Food Safety
Produce supplier says FDA cleared it in salmonella outbreak - National Trade Productions
Emergency preparedness conferences well attended - Q1 Labs Inc.
Real-time network surveillance solution selected by four healthcare institutions - Tobacco Use
Helena, Montana, smoking ban in limbo, will stay there for now - Accelerate Brain Cancer Cure
Groups co-fund brain cancer genetics research at UCSF - Bioheart, Inc.
Alliance to bring stem cell recruiting myoblast technology to clinic - More from this issue of Genetics and Environmental Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
